siemens.com wurde im letzten Monat von mehr als 10.000 Nutzern besucht
Improve Lab Quality & Productivity, Create Transparency and Gain Energy Savings. Act Now. Siemens Offers Green Lab Solutions, Biocontainment, Regulatory Compliance and More.
- Future proof your lab
Embrace big data to connect with
workers and optimize your lab.
- Decarbonization
Learn how decarbonization will
shape the life sciences.
- A green lab approach
A Green Lab balances temp, humidity
& lighting for occupants' safety.
- Consulting Engineers
Lab control specification
and design at your fingertips.
- Future proof your lab
Suchergebnisse
Suchergebnisse:
Spark Therapeutics is challenging the inevitability of genetic disease by discovering, developing and delivering treatments in ways unimaginable – until now.
- We are Spark
Spark is a member of the Roche Group. Our mission. We unlock...
- Our Products
Spark Therapeutics, Inc. 3737 Market Street Philadelphia, PA...
- Our scientific platform & programs
Spark Therapeutics is developing SPK-3006, an...
- Healthcare professionals
References: Berger W, Kloeckener-Gruissem B, Neidhardt J....
- Join the Spark team
The Truths We Live By. We proudly say, “We are Spark.”...
- Contact Us
For Medical Inquiries Call: 1-866-MI-SPARK (1-866-647-7275)...
- Inherited Retinal Diseases
Inherited retinal diseases (IRDs) are a group of rare...
- Hemophilia
Hemophilia is typically inherited, meaning that it’s passed...
- We are Spark
The company is currently developing several gene therapies to target a suite of diseases, including Haemophilia A and B, and several central nervous system diseases. In December 2019, the company was acquired by Hoffmann-La Roche for $4.3 billion. [6] [7] It now continues to operate as an independent subsidiary. [8]
Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.
12. Dez. 2022 · PHILADELPHIA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated gene therapy company today announced updated...
- Spark Therapeutics, Inc.
23. Feb. 2022 · Spark Therapeutics is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies. Founded in 2013, Spark Therapeutics is the first company in the U.S. to receive FDA approval of a gene therapy for a genetic disease.
Spark Therapeutics, Inc. | 87,207 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...
Discover hi-tech solutions for pharma containment at ChargePoint Technology. Safeguard your pharmaceuticals with our patented powder transfer systems